Bai F - Search Results

1

Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.

Zheng RH, Zhang WW, Ji YN, Bai XJ, Yan CP, Wang J, Bai F, Zhao ZQ. Zheng RH, et al. Among authors: bai f, bai xj. Eur J Pharmacol. 2020 Sep 15;883:173318. doi: 10.1016/j.ejphar.2020.173318. Epub 2020 Jul 1. Eur J Pharmacol. 2020. PMID: 32621911

2

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.

Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ. Zhang WW, et al. Among authors: bai f. Drug Des Devel Ther. 2017 Oct 16;11:3019-3033. doi: 10.2147/DDDT.S144807. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29081650 Free PMC article.

3

Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.

Zheng RH, Bai XJ, Zhang WW, Wang J, Bai F, Yan CP, James EA, Bose HS, Wang NP, Zhao ZQ. Zheng RH, et al. Among authors: bai f, bai xj. Drug Des Devel Ther. 2019 Aug 6;13:2745-2757. doi: 10.2147/DDDT.S213910. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31496651 Free PMC article.

4

Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.

Bai F, Zhang LH, Zhang WW, Zheng RH, Eskew JR, Bennett J, Wang NP, Bose HS, Zhao ZQ. Bai F, et al. Eur J Pharmacol. 2020 Jan 15;867:172844. doi: 10.1016/j.ejphar.2019.172844. Epub 2019 Dec 4. Eur J Pharmacol. 2020. PMID: 31811859

5

Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.

Banks TE, Rajapaksha M, Zhang LH, Bai F, Wang NP, Zhao ZQ. Banks TE, et al. Among authors: bai f. Eur J Pharmacol. 2022 Jul 15;927:175048. doi: 10.1016/j.ejphar.2022.175048. Epub 2022 May 26. Eur J Pharmacol. 2022. PMID: 35644422

6

Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.

Zhang LH, Pang XF, Bai F, Wang NP, Shah AI, McKallip RJ, Li XW, Wang X, Zhao ZQ. Zhang LH, et al. Among authors: bai f. Cardiovasc Drugs Ther. 2015 Jun;29(3):243-55. doi: 10.1007/s10557-015-6592-7. Cardiovasc Drugs Ther. 2015. PMID: 25994830

7

Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.

Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, Zhao ZQ. Pang XF, et al. Among authors: bai f. Drug Des Devel Ther. 2015 Nov 11;9:6043-54. doi: 10.2147/DDDT.S95333. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26648693 Free PMC article.

8

Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction.

Wang ZF, Wang NP, Harmouche S, Philip T, Pang XF, Bai F, Zhao ZQ. Wang ZF, et al. Among authors: bai f. J Surg Res. 2017 May 1;211:178-190. doi: 10.1016/j.jss.2016.11.046. Epub 2016 Dec 5. J Surg Res. 2017. PMID: 28501115

9

Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.

Zhang WW, Zheng RH, Bai F, Sturdivant K, Wang NP, James EA, Bose HS, Zhao ZQ. Zhang WW, et al. Among authors: bai f. Mol Biol Rep. 2020 Feb;47(2):1207-1222. doi: 10.1007/s11033-019-05222-7. Epub 2019 Dec 9. Mol Biol Rep. 2020. PMID: 31820314

10

Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart.

Pang XF, Zhang LH, Bai F, Wang NP, Ijaz Shah A, Garner R, Zhao ZQ. Pang XF, et al. Among authors: bai f. Eur J Pharmacol. 2015 Jan 5;746:22-30. doi: 10.1016/j.ejphar.2014.11.001. Epub 2014 Nov 11. Eur J Pharmacol. 2015. Retraction in: Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025 Retraction in: Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025 PMID: 25445044 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,312 results

Search Page

Filters